Literature DB >> 19891689

Cutaneous leishmaniasis treated with itraconazole.

A Baroni, F S Aiello, A Vozza, G Vozza, F Faccenda, M Brasiello, E Ruocco.   

Abstract

Leishmaniasis is a human disease produced by a parasite of the Leishmania genus transmitted by prick of an infected female sandfly. The disease occurs clinically with either cutaneous, mucocutaneous or visceral form, depending on the infective species and the immune status of the patient. Antimonial drugs are the current treatment of choice for all clinical forms. We report a case of cutaneous Leishmaniasis in a young girl successfully treated with itraconazole.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891689     DOI: 10.1111/j.1529-8019.2009.01264.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

1.  VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.

Authors:  Galina I Lepesheva; Tatiana Y Hargrove; Girish Rachakonda; Zdzislaw Wawrzak; Sébastien Pomel; Sandrine Cojean; Pius N Nde; W David Nes; Charles W Locuson; M Wade Calcutt; Michael R Waterman; J Scott Daniels; Philippe M Loiseau; Fernando Villalta
Journal:  J Infect Dis       Date:  2015-04-15       Impact factor: 5.226

Review 2.  Drug strategies targeting CYP51 in neglected tropical diseases.

Authors:  Jun Yong Choi; Larissa M Podust; William R Roush
Journal:  Chem Rev       Date:  2014-10-22       Impact factor: 60.622

3.  In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.

Authors:  Sara Teixeira de Macedo-Silva; Julio A Urbina; Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 4.  Synthesis and Biological Activity of Sterol 14α-Demethylase and Sterol C24-Methyltransferase Inhibitors.

Authors:  David J Leaver
Journal:  Molecules       Date:  2018-07-17       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.